Effects of prostacyclin on systemic and coronary hemodynamics in the dog
- 1 November 1981
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 102 (5), 835-840
- https://doi.org/10.1016/0002-8703(81)90033-8
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Myocardial prostaglandin E release by nitroglycerin and modification by indomethacinThe American Journal of Cardiology, 1980
- Platelet aggregation in aortic and coronary venous blood in patients with and without coronary disease. 3. Role of tachycardia stress and propranolol.Circulation, 1978
- Prostacyclin: A Potentially Valuable Agent for Preserving Myocardial Tissue in Acute Myocardial IschemiaScience, 1978
- Prostacyclin (PGX) is the endogeneous metabolite responsible for relaxation of coronary arteries induced by arachidonic acidProstaglandins, 1977
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 1977
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Possible contributions of endogenous prostaglandins to the control of blood pressure.Circulation Research, 1975
- Regulation of postocclusive hyperemia by endogenously synthesized prostaglandins in the dog heart.JCI Insight, 1975
- Anoxia-induced release of prostaglandins in rabbit isolated hearts.Circulation Research, 1975
- Prostaglandin release by the isolated perfused rabbit heartProstaglandins, 1973